Literature DB >> 2717884

Translocation of protein kinase C to subcellular fractions of human neutrophils.

N O Christiansen1, N Borregaard.   

Abstract

The subcellular localization of protein kinase C in unstimulated human neutrophils and neutrophils stimulated by phorbol-myristate-acetate (PMA), 1-oleoyl-2-acetyl-rac-glycerol (OAG), and ionomycin was investigated in subcellular fractions obtained by nitrogen cavitation and Percoll density gradient centrifugation. Protein kinase C was found to be localized mainly in the cytosol in unstimulated cells, whereas significant translocation to fractions containing the plasma membrane was observed after stimulation by PMA, OAG, and ionomycin. At the same time, phospholipid-insensitive protein kinase activity appeared in the cytosol and the plasma membrane fractions. To determine whether binding of protein kinase C occurred to the plasma membrane or to intracellular membranes that had translocated to the plasma membrane, we investigated the ability of isolated azurophil, specific and secretory granules, and plasma membrane vesicles to bind protein kinase C in response to addition of PMA and OAG. Only fractions containing plasma membranes and secretory granules were able to bind protein kinase C. The observation explains the selective activation of plasma membrane structures by protein kinase C.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2717884     DOI: 10.1111/j.1365-3083.1989.tb01140.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  2 in total

1.  Phorbol myristate acetate induction of chemotactic migration of human polymorphonuclear neutrophils.

Authors:  W L Gabler; W W Bullock; H R Creamer
Journal:  Inflammation       Date:  1993-08       Impact factor: 4.092

2.  Transmembrane signaling in human polymorphonuclear neutrophils: 15(S)-hydroxy-(5Z,8Z,11Z,13E)-eicosatetraenoic acid modulates receptor agonist-triggered cell activation.

Authors:  R J Smith; J M Justen; E G Nidy; L M Sam; J E Bleasdale
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.